AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

"Medical Journeys" chart a path each step of the way for physicians and patients and provide continual resources and support, ...

Do you find yourself sneezing, itching or battling watery eyes as the seasons change? If so, you may have a pollen ...

GSK's experimental IL-5 inhibitor depemokimab has shown its potential in a pair of phase 3 trials in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). The company said this morning ...

WILMINGTON, Del., November 08, 2024--Positive high-level results from the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps (CRSwNP [nasal polyps]) showed that ...

What are the options for drug addiction treatment? In addition to residential treatment and partial hospitalization, there are many treatment possibilities for addiction. It is difficult to know ...

Toll Brothers's Options Frenzy: What You Need to Know 10 Health Care Stocks Whale Activity In Today's Session 10 Consumer Discretionary Stocks Whale Activity In Today's Session Unusual options ...

At one time, and because of the risk management challenges involved, listed options trading was mostly done by professionals and market makers with limited public participation. Today, you can ...

Birth control is how you prevent pregnancy. There are lots of different birth control options out there. We’re here to help you figure it all out.